We are live on ! Find out more
GMAB icon

Genmab
GMAB

233 hedge funds and large institutions have $1.67B invested in Genmab in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 56 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 21

71% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 56

9% more funds holding

Funds holding: 213 → 233 (+20)

8.68% more ownership

Funds ownership: 63.15% → 71.83% (+8.7%)

6% more capital invested

Capital invested by funds: $1.59B → $1.67B (+$89.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

22% less call options, than puts

Call options by funds: $1.61M | Put options by funds: $2.07M

Holders
233
Holders Change
+20
Holders Change %
+9.39%
% of All Funds
3.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
96
Reduced
56
Closed
21
Calls
$1.61M
Puts
$2.07M
Net Calls
-$459K
Net Calls Change
-$379K

Top Buyers

Rank Fund Capital Flow
1
HL
Harding Loevner
New Jersey
+$116M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$17.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$12.8M
5
Northern Trust
Northern Trust
Illinois
+$9.68M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$14.8M
2
Macquarie Group
Macquarie Group
Australia
-$13.2M
3
Jane Street
Jane Street
New York
-$6.57M
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.13M
5
ACM
Aquilo Capital Management
California
-$4.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFA
226
Farther Finance Advisors
California
$917 +$991 +26 New
CSC
227
Caldwell Sutter Capital
California
$776 – – –
BCM
228
Bourgeon Capital Management
Connecticut
$671 +$724 +19 New
Fisher Asset Management
229
Fisher Asset Management
Washington
$670 – – –
TWD
230
True Wealth Design
Ohio
$494 – – –
GWSG
231
GPS Wealth Strategies Group
Colorado
$353 +$381 +10 New
Barclays
232
Barclays
United Kingdom
$352 – – –
AWM
233
Abound Wealth Management
Tennessee
$318 – – –
Two Sigma Investments
234
Two Sigma Investments
New York
– -$5.13M -134,913 Closed
Voloridge Investment Management
235
Voloridge Investment Management
Florida
– -$2.32M -61,055 Closed
ACM
236
Arlington Capital Management
Illinois
– -$1.39M -36,489 Closed
SFI
237
Susquehanna Fundamental Investments
Pennsylvania
– -$736K -19,371 Closed
Ensign Peak Advisors
238
Ensign Peak Advisors
Utah
– -$692K -18,200 Closed
CCIA
239
Campbell & Co Investment Adviser
Maryland
– -$601K -15,804 Closed
EGM
240
Engineers Gate Manager
New York
– -$442K -11,617 Closed
DTL
241
Dynamic Technology Lab
Singapore
– -$309K -8,120 Closed
VIA
242
Vident Investment Advisory
Georgia
– -$298K -7,842 Closed
Susquehanna International Group
243
Susquehanna International Group
Pennsylvania
– -$234K -6,147 Closed
Pacer Advisors
244
Pacer Advisors
Pennsylvania
– -$221K -5,810 Closed
EI
245
Ellevest Inc
New York
– -$213K -5,609 Closed
SSG
246
Summit Securities Group
New York
– -$2.1M -5,551 Closed
TAIM
247
TD Ameritrade Investment Management
Nebraska
– -$86K -2,254 Closed
Deutsche Bank
248
Deutsche Bank
Germany
– -$74.2K -1,951 Closed
BG
249
Bollard Group
Massachusetts
– -$16K -427 Closed
Bessemer Group
250
Bessemer Group
New Jersey
– -$10K -250 Closed
7 8 9
10
11

GMAB Hedge Fund Activity: Q3 2023 in Review

233 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2023, worth a combined $1.67B — up 5.6% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new GMAB positions and 21 closed out — a net gain of 20 holders — while 96 added to existing stakes and 56 trimmed.

The largest buyer was Harding Loevner, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $14.8M.

  • 233 institutional investors held Genmab (GMAB) as of Q3 2023, up from 213 in Q2 2023.
  • Funds reported $1.67B of Genmab stock for Q3 2023, up 5.6% quarter-over-quarter.
  • 41 funds opened new Genmab positions in Q3 2023 and 21 closed out, a net change of +20 holders.
  • The largest Genmab buyer in Q3 2023 was Harding Loevner, an estimated $116M added.
  • The largest Genmab seller in Q3 2023 was BlackRock, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2023.